NEO: Other company developments

Item 8.01 Other Events. On June 17, 2026, NeoGenomics, Inc. (the “Company”) issued a press release relating to the pricing of its offering of convertible senior notes due 2032 to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Convertible Notes Offering”). A copy of the press release relating to the Convertible Notes Offering is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein. This Current Report on Form 8-K, including the exhibit attached hereto, does not constitute an offer to sell or the solicitation of an offer to buy any securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offering, solicitation or sale would be unlawful. Item 9.01 Financial Statements and Exhibits. (d) Exhibits. 99.1 Press release relating to the Pricing of the Convertible Note Offering issued by NeoGenomics, Inc. on June 17, 2026. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NEOGENOMICS, INC. Date: June 17, 2026 By: /s/ Alicia C. Olivo Name: Alicia C. Olivo Title: Executive Vice President, General Counsel & Secretary